Compass Wealth Management LLC Purchases 83,053 Shares of Option Care Health, Inc. (NASDAQ:OPCH)

Compass Wealth Management LLC lifted its position in shares of Option Care Health, Inc. (NASDAQ:OPCH) by 75.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 193,128 shares of the company’s stock after purchasing an additional 83,053 shares during the quarter. Option Care Health accounts for 1.4% of Compass Wealth Management LLC’s portfolio, making the stock its 18th largest position. Compass Wealth Management LLC owned approximately 0.11% of Option Care Health worth $6,045,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Vanguard Group Inc. raised its holdings in shares of Option Care Health by 1.6% during the fourth quarter. Vanguard Group Inc. now owns 19,626,205 shares of the company’s stock worth $661,207,000 after acquiring an additional 306,853 shares during the period. Wellington Management Group LLP raised its holdings in shares of Option Care Health by 157.1% during the fourth quarter. Wellington Management Group LLP now owns 7,445,556 shares of the company’s stock worth $250,841,000 after acquiring an additional 4,549,164 shares during the period. Thrivent Financial for Lutherans raised its holdings in shares of Option Care Health by 9.1% during the second quarter. Thrivent Financial for Lutherans now owns 5,459,119 shares of the company’s stock worth $151,218,000 after acquiring an additional 455,310 shares during the period. Westfield Capital Management Co. LP raised its holdings in shares of Option Care Health by 15.4% during the first quarter. Westfield Capital Management Co. LP now owns 5,171,385 shares of the company’s stock worth $173,448,000 after acquiring an additional 688,653 shares during the period. Finally, Dimensional Fund Advisors LP raised its holdings in shares of Option Care Health by 6.5% during the second quarter. Dimensional Fund Advisors LP now owns 3,605,271 shares of the company’s stock worth $99,870,000 after acquiring an additional 218,844 shares during the period. 98.05% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Barrington Research lifted their price target on shares of Option Care Health from $38.00 to $40.00 and gave the company an “outperform” rating in a research note on Thursday, August 1st. JMP Securities lifted their price target on shares of Option Care Health from $36.00 to $37.00 and gave the company a “market outperform” rating in a research note on Monday, September 30th.

Option Care Health Stock Performance

Shares of OPCH traded down $0.39 during midday trading on Thursday, reaching $30.52. The stock had a trading volume of 454,041 shares, compared to its average volume of 1,401,700. The firm has a 50 day simple moving average of $31.04 and a 200-day simple moving average of $30.16. Option Care Health, Inc. has a one year low of $26.11 and a one year high of $34.63. The firm has a market cap of $5.30 billion, a PE ratio of 20.34, a P/E/G ratio of 2.21 and a beta of 1.29. The company has a current ratio of 1.76, a quick ratio of 1.36 and a debt-to-equity ratio of 0.78.

Option Care Health (NASDAQ:OPCH) last announced its quarterly earnings data on Wednesday, July 31st. The company reported $0.30 EPS for the quarter, beating analysts’ consensus estimates of $0.27 by $0.03. Option Care Health had a net margin of 4.60% and a return on equity of 14.82%. The company had revenue of $1.23 billion during the quarter, compared to the consensus estimate of $1.17 billion. During the same quarter last year, the firm posted $0.63 EPS. The company’s quarterly revenue was up 14.8% on a year-over-year basis. As a group, sell-side analysts anticipate that Option Care Health, Inc. will post 1.22 EPS for the current year.

Insider Buying and Selling

In related news, Director Elizabeth Quadros Betten sold 47,531 shares of Option Care Health stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total transaction of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company’s stock, valued at approximately $663,429.51. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other Option Care Health news, Director Elizabeth Quadros Betten sold 47,531 shares of the business’s stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $31.09, for a total value of $1,477,738.79. Following the completion of the sale, the director now owns 21,339 shares of the company’s stock, valued at $663,429.51. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, CFO Michael H. Shapiro sold 23,217 shares of the business’s stock in a transaction dated Thursday, August 22nd. The shares were sold at an average price of $30.95, for a total transaction of $718,566.15. Following the completion of the sale, the chief financial officer now directly owns 247,317 shares of the company’s stock, valued at $7,654,461.15. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.64% of the stock is currently owned by insiders.

Option Care Health Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.